Will the FDA approve Gilead's lenacapavir for HIV pre-exposure prophylaxis (PrEP) by the end of 2026?

Will the FDA approve Gilead's lenacapavir for HIV pre-exposure prophylaxis (PrEP) by the end of 2026? | Prophecy